Silver-enhanced in situ hybridisation (SISH) detection assay for HER2 gene status determination in breast carcinoma

被引：0
|
作者：
Patakiouta, F. [1 ]
Koumpanaki, M. [1 ]
Anestakis, D. [1 ]
Zafeiriou, G. [1 ]
Paraskevopoulos, P. [1 ]
Papakotoulas, P. [1 ]
Papazisis, T. K. [1 ]
Bousoulegas, A. [1 ]
机构：
[1] Theagen Canc Hosp Thessaloniki, Thessaloniki, Greece
来源：
VIRCHOWS ARCHIV | 2009年 / 455卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：103 / 103
页数：1
相关论文
共 50 条
  • [41] HER2 status in operable breast cancers from Vietnamese women: Analysis by immunohistochemistry (IHC) and automated silver enhanced in situ hybridization (SISH)
    Vu Hong Thang
    Tani, Edneia
    Ta Thanh Van
    Krawiec, Kamilla
    Skoog, Lambert
    ACTA ONCOLOGICA, 2011, 50 (03) : 360 - 366
  • [42] Agreement between chromogenic in situ hybridisation (CISH) and FISH in the determination of HER2 status in breast cancer
    Arnould, L
    Denoux, Y
    MacGrogan, G
    Penault-Llorca, F
    Fiche, M
    Treilleux, I
    Mathieu, MC
    Vincent-Salomon, A
    Vilain, MO
    Couturier, J
    BRITISH JOURNAL OF CANCER, 2003, 88 (10) : 1587 - 1591
  • [43] Agreement between chromogenic in situ hybridisation (CISH) and FISH in the determination of HER2 status in breast cancer
    L Arnould
    Y Denoux
    G MacGrogan
    F Penault-Llorca
    M Fiche
    I Treilleux
    M C Mathieu
    A Vincent-Salomon
    M O Vilain
    J Couturier
    British Journal of Cancer, 2003, 88 : 1587 - 1591
  • [44] Comparison of immunohistochemistry and chromogenic in situ hybridisation for the determination of HER2 status in breast and gastric cancer.
    Shi, D.
    Zhang, G.
    Liang, X.
    Hou, J.
    Kang, S.
    Zhu, W.
    Chen, L.
    Zhou, Y.
    Li, X.
    Shao, Y.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S51 - S51
  • [45] Delineation of HER2 Gene Status in Breast Carcinoma by Silver in Situ Hybridization is Reproducible among Laboratories and Pathologists
    Carbone, Antonino
    Botti, Gerardo
    Gloghini, Annunziata
    Simone, Gianni
    Truini, Mauro
    Curcio, Maria Pia
    Gasparini, Patrizia
    Mangia, Anita
    Perin, Tiziana
    Saivi, Sandra
    Testi, Adele
    Verderio, Paolo
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2008, 10 (06): : 527 - 536
  • [46] Bright-field In Situ Hybridization for HER2 Gene Amplification in Breast Cancer Using Tissue Microarrays Correlation Between Chromogenic (CISH) and Automated Silver-enhanced (SISH) Methods With Patient Outcome
    Francis, Glenn D.
    Jones, Mark A.
    Beadle, Geoffrey F.
    Stein, Sandra R.
    DIAGNOSTIC MOLECULAR PATHOLOGY, 2009, 18 (02) : 88 - 95
  • [47] Comparison of Chromogenic in Situ Hybridisation (CISH) with Immunohistochemistry (IHC) for the Detection of HER2 Status in Breast Cancer
    Desai, S.
    Shirsat, H.
    Epari, S.
    Bagal, R.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2009, 11 (06): : 659 - 660
  • [48] Delineation of HER2 Gene Status in Korean Breast Cancers by Standardized Immunohistochemistry (IHC) and Silver In Situ Hybridization (SISH): Comparison of Local IHC Result with Central IHC and SISH Results
    Bae, Y. K.
    Gong, G.
    Kang, J.
    Lee, A.
    Cho, E. Y.
    Lee, J. S.
    Suh, K-S
    Lee, D. W.
    CANCER RESEARCH, 2010, 70
  • [49] Determination of HER2 Gene Amplification in Breast Cancer using Dual-color Silver Enhanced in situ Hybridization (dc-SISH) and Comparison with Fluorescence ISH (FISH)
    Unal, Betul
    Karaveli, Fatma Seyda
    Pestereli, Hadice Elif
    Erdogan, Gulgun
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (10) : 6131 - 6134
  • [50] Determination of HER2 gene amplification by chromogenic in situ hybridization (CISH) in breast carcinoma
    Neagu, M.
    Butur, G.
    Ardeleanu, C.
    FEBS JOURNAL, 2012, 279 : 328 - 328
12345